Emergency Department Management of the Salicylate-Poisoned Patient

Emergency Medicine Clinics of North America

Volumn 25, Issue 2, 2007, Pages 333-346

  O'Malley, Gerald F ^a,b,c,d  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d Philadelphia Poison Control Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED CARBON; ANALGESIC AGENT; BICARBONATE; CAMPHOR; INFUSION FLUID; MENTHOL; PARACETAMOL; POTASSIUM; SALICYLIC ACID; SALICYLIC ACID METHYL ESTER; SORBITOL;

ABDOMINAL PAIN; ARTIFICIAL VENTILATION; BEZOAR; BRAIN EDEMA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIGESTIVE SYSTEM ULCER; DISEASE COURSE; DISORDERS OF ACID BASE BALANCE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FATALITY; DRUG INTOXICATION; DRUG MECHANISM; DRUG METABOLISM; EMERGENCY HEALTH SERVICE; GASTROINTESTINAL SYMPTOM; HEMODIALYSIS; HEMORRHAGIC GASTRITIS; HUMAN; HYPERVENTILATION; HYPOKALEMIA; INCIDENCE; KIDNEY FAILURE; LABORATORY TEST; LIVER FAILURE; LUNG CONGESTION; LUNG EDEMA; METABOLIC ACIDOSIS; MUSCLE RIGIDITY; MYOCARDITIS; NAUSEA; NOMOGRAM; ORGAN INJURY; OTOTOXICITY; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; RESUSCITATION; REVIEW; STOMACH LAVAGE; STOMACH SPASM; TINNITUS; VOMITING;

EID: 34247555490     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2007.02.012     Document Type: Review

References (82)

1. Hedner T., and Everts B. The early clinical history of salicylates in rheumatology and pain. Clin Rheumatol 17 1 (1998) 17-25
2. Mueller R.L., and Scheidt S. History of drugs for thrombotic disease. Discovery, development, and directions for the future. Circulation 89 1 (1994) 432-449
3. Hare L.G., Woodside J.V., and Young I.S. Dietary salicylates. Journal of Clinical Pathology 56 (2003) 649-650
4. Fink C.W. Acute versus chronic salicylate poisoning. Pediatrics 71 5 (1983) 862-863
5. Flomenbaum N. Salicylates. In: Goldfrank L.R., Flomenbaum N., and Lewin N. (Eds). Goldfrank's toxicologic emergencies. 7th edition (2003), McGraw-Hill Medical Publishing Division, New York 513
6. Vivian A.S., and Goldberg I.B. Recognizing chronic salicylate intoxication in the elderly. Geriatrics 37 11 (1982) 91-97
7. Anderson R.J., Potts D.E., Gabow P.A., et al. Unrecognized adult salicylate intoxication. Ann Intern Med 85 6 (1976) 745-748
8. Jones A. Over-the-counter analgesics: a toxicologic perspective. Am J Ther 9 3 (2002) 245-257
9. Pirmohamed M., James S., Meakin S., et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329 7456 (2004) 15-19
10. Wazaify M., Kennedy S., Hughes C.M., et al. Prevalence of over-the-counter drug-related overdoses at accident and emergency departments in Northern Ireland-a retrospective evaluation. J Clin Pharm Ther 30 1 (2005) 39-44
11. Watson W.A., Litovitz T.L., Rodgers Jr. G.C., et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 23 5 (2005) 589-666
12. Gittelman D.K. Chronic salicylate intoxication. South Med J 86 6 (1993) 683-685
13. Rodgers G.B. The effectiveness of child-resistant packaging for aspirin. Arch Pediatr Adolesc Med 156 9 (2002) 929-933
14. Hawton K., Simkins S., Decks J., et al. UK legislation on analgesic packs: before-and-after study of long-term effect on poisonings. BMJ 329 7474 (2004) 1076
15. Sheen C.L., Dillon J.F., Bateman D.N., et al. Paracetamol pack size restriction: the impact on paracetamol poisoning and the over-the-counter supply of paracetamol, aspirin, and ibuprofen. Pharmacoepidemiol Drug Saf 11 4 (2002) 329-331
16. Yip L., Dart R.C., and Gabrow P.A. Concepts and controversies in salicylate toxicity. Emerg Med Clin N Am 12 2 (1994) 351-364
17. Petrescu I., and Tarba C. Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat. Biochim Biophys Acta 1318 3 (1997) 385-394
18. Krause D.S., Wolf B.A., and Shaw L.M. Acute aspirin overdose: mechanisms of toxicity. Ther Drug Monit 14 6 (1992) 441-451
19. Temple A.R. Pathophysiology of aspirin overdosage toxicity, with implications for management. [review]. Pediatrics 62 5 Pt 2 Suppl (1978) 873-876
20. Leatherman J.W., and Schmitz P.G. Fever, hyperdynamic shock, and multiple-system organ failure. A pseudo-sepsis syndrome associated with chronic salicylate intoxication. Chest 100 5 (1991) 1391-1396
21. Schwartz R., and Landy G. Organic acid excretion in salicylate intoxication. J Pediatr 66 (1965) 658-666
22. Hill J.B. Salicylate intoxication. N Engl J Med 288 (1973) 1110-1113
23. Rivera W., Kleinschmidt K.C., Velez L.I., et al. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother 38 7-8 (2004) 1186-1188
24. Myers B., Evans D.N., Rhodes J., et al. Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract. Gut 28 (1987) 196-200
25. Schanker L.S., Tocco D.J., Brodie B.B., et al. Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther 123 1 (1958) 81-88
26. Singh P., and Roberts M.S. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J Pharmacokinet Biopharm 21 4 (1993) 368-370
27. Singh P., and Roberts M.S. Skin permeability and local tissue concentrations of nonsteroidal anti- inflammatory drugs after topical application. J Pharmacol Exp Ther 268 1 (1994) 144-151
28. Cross S.E., Anderson C., and Roberts M.S. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. Br J Clin Pharmacol 46 1 (1998) 29-35
29. Martin D., Valdez J., Boren J., et al. Dermal absorption of camphor, menthol, and methyl salicylate in humans. J Clin Pharmacol 44 (2004) 1151-1157
30. Bell A.J., and Duggin G. Acute methyl salicylate toxicity complicating herbal skin treatment for psoriasis. Emerg Med (Fremantle) 14 2 (2002) 188-190
31. Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol 38 1 (1999) 20-22
32. Taylor J.R., and Halprin K.M. Percutaneous absorption of salicylic acid. Arch Dermatol 111 6 (1975) 740-743
33. Martin L. All you really need to interpret arterial blood gases. 2nd edition (1999), Philadelphia: Lippincott, Williams and Wilkins
34. Chrichton J.U., and Elliott G.B. Salicylate-a dangerous drug in infancy and childhood. Can Med Assoc J 83 (1960) 1144
35. Done A.K. Treatment of salicylate poisoning: review of personal and published experiences. Clin Toxicol 1 (1968) 451
36. Gaudreault P., Temple A.R., and Lovejoy F.H. The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison. Pediatrics 70 (1982) 567-568
37. Jepsen F., and Ryan M. Poisoning in children. Current Paediatrics 15 7 (2005) 563-568
38. Wrathall G., Sinclair R., Moore A., et al. Three case reports of the use of haemodiafiltration in the treatment of salicylate overdose. Hum Exp Toxicol 20 9 (2001) 491-495
39. Grabe D.W., Manley H.J., Kim J.S., et al. Respiratory distress caused by salicylism confirmed by lung biopsy. Clin Drug Investig 17 1 (1999) 79-81
40. Proudfoot A.T. Toxicity of salicylates. Am J Med 75 Suppl (1983) 100-102
41. Cazals Y. Auditory sensori-neural alterations induced by salicylate. Prog Neurobiol 62 6 (2000) 583-631
42. Wecker H., and Laubert A. Reversible hearing loss in acute salicylate intoxication. HNO 52 4 (2004) 347-351
43. Mongan E., Kelly P., Nies K., et al. Tinnitus as an indication of therapeutic serum salicylate levels. JAMA 226 2 (1973) 142-145
44. Taylor JR, Streetman, DS, Castle SS. Medication bezoars: a literature review and report of a case. Ann Pharmacother 1998;32(9):940-6.
45. Stack P.E., and Thomas E. Pharmacobezoar: an evolving new entity. Dig Dis 13 6 (1995) 356-364
46. Gabow P.A., Anderson R.J., Potts D.E., et al. Acid-base disturbances in the salicylate-intoxicated adult. Arch Intern Med 138 (1978) 1482-1483
47. Dale C., Aulaqi A.A., Baker J., et al. Assessment of a point-of-care test for paracetamol and salicylate in blood. QJM 98 2 (2005) 113-118
48. Graham C.A., Irons A.J., and Munro P.T. Paracetamol and salicylate testing: routinely required for all overdose patients?. Eur J Emerg Med 13 1 (2006) 26-28
49. Wood D.M., Dargan P.I., and Jones A.L. Measuring plasma salicylate concentrations in all patients with drug overdose or altered consciousness: is it necessary?. Emerg Med J 22 6 (2005) 401-403
50. Dugandzic R.M., Tierney M.G., Dickinson G.E., et al. Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication. Ann Emerg Med 18 (1989) 1186-1190
51. Chalasani N., Roman J., and Jurado R.L. Systemic inflammatory response syndrome caused by chronic salicylate intoxication. South Med J 89 5 (1996) 479-482
52. Paul B.N. Salicylate poisoning in the elderly: diagnostic pitfalls. J Am Geriatr Soc 20 (1972) 388-389
53. Bailey R.B., and Jones S.R. Chronic salicylate intoxication: a common cause of morbidity in the elderly. J Am Geriatr Soc 37 (1989) 556
54. Steele T.E., and Morton W.A. Salicylate-induced delirium. Psychosomatics 27 (1986) 455-456
55. Dargan P.I., Wallace C.I., and Jones A.L. An evidence-based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J 19 (2002) 206-209
56. McGuigan M.A. A two-year review of salicylate deaths in Ontario. Arch Intern Med 147 (1987) 510-512
57. Thisted B., Krantz T., and Stroom J. Acute salicylate self-poisoning in 177 consecutive patients treated in ICU. Acta Anaesthesiol Scand 31 4 (1987) 312-316
58. Pena-Alonso Y.R., Montoya-Cabrera M.A., and Bustos-Cordoba E. Aspirin intoxication in a child associated with myocardial necrosis: Is this a drug-related lesion?. Pediatr Dev Pathol 3 (2003) 342-347
59. Done A.K. Salicylate intoxication: significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics 26 (1960) 805-806
60. Done A.K. Aspirin overdosage: incidence, diagnosis, and management. Pediatrics 62 Suppl (1978) 890-897
61. Kulig K. Salicylate intoxication: is the Done nomogram reliable?. [Comment in AACT]. Clinical Toxicology UPDATE 3 2 (1990) 2-3
62. Chabali R. Diagnostic use of anion and osmolal gaps in pediatric emergency medicine. Pediatr Emerg Care 13 3 (1997) 204-210
63. Litovitz T., and Manoguerra A. Comparison of pediatric poisoning hazards: an analysis of 3.8 million exposure incidents. A report from the American Association of Poison Control Centers. Pediatrics 89 6 Pt 1 (1992) 999-1006
64. Mitchell A.A., Lovejoy Jr. F.H., Slone D., et al. Acetaminophen and aspirin. Prescription, use, and accidental ingestion among children. Am J Dis Child 136 11 (1982) 976-979
65. Erzurumlu K., Malagirt Z., Bektas A., et al. Gastrointestinal bezoars: a retrospective analysis of 34 cases. World J Gastroenterol 11 12 (2005) 1813-1817
66. Proudfoot A.T., Krenzelok E.P., and Vale J.A. Position paper on urine alkalinization. J Toxicol Clin Toxicol 42 1 (2004) 1-26
67. Greenberg M.I., Hendrickson R.G., and Hofman M. Deleterious effects of endotracheal intubation in salicylate poisoning. Ann Emerg Med 41 4 (2003) 583-584
68. Kirshenbaum L.A., Mathews S.C., Sitar D.S., et al. Does multiple-dose charcoal therapy enhance salicylate excretion?. Arch Intern Med 150 6 (1990) 1281-1283
69. Park G.D., Spector R., Goldberg M.J., et al. Expanded role of charcoal therapy in the poisoned and overdosed patient. Arch Intern Med 146 5 (1986) 969-973
70. Vale J.A., Krenzolak E., and Barceloux G.D. Position statement and practice guidelines on the use of multidose activated charcoal in the treatment of acute poisoning. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 37 6 (1999) 731-751
71. Lheureux P., and Tenenbein M. Position paper: whole bowel irrigation. J Toxicol Clin Toxicol 42 6 (2004) 843-854
72. Tenenbein M. Position statement: whole bowel irrigation. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 35 7 (1997) 753-762
73. Daly F.F., Little M., and Murray L. A risk assessment-based approach to the management of acute poisoning. Emerg Med J 23 5 (2006) 396-399
74. Heard K. The changing indications of gastrointestinal decontamination in poisonings. Clin Lab Med 26 1 (2006) 1-12 vii
75. Worthley L.I. Clinical toxicology: part I. Diagnosis and management of common drug overdosage. Crit Care Resusc 4 3 (2002) 192-215
76. Heard K. Gastrointestinal decontamination. Med Clin North Am 89 6 (2005) 1067-1078
77. Osterhoudt K.C., Durbin D., Alpern E.R., et al. Risk factors for emesis after therapeutic use of activated charcoal in acutely poisoned children. Pediatrics 113 4 (2004) 806-810
78. Proudfoot A.T., Krenzelok E.P., Brent J., et al. Does urinary alkalinization increase salicylate elimination? If so, why?. Toxicol Rev 22 3 (2003) 129-136
79. Chang Y.L., Biagi B., and Giebish G. Control mechanism for bicarbonate transport across the rat proximal convoluted tubule. Am J Physiol 242 (1982) 532-543
80. Lund B., Seifert S.A., and Mayersohn M. Efficacy of sustained low-efficiency dialysis in the treatment of salicylate toxicity. Nephrol Dial Transplant 20 7 (2005) 1483-1484
81. Higgins R.M., Connolly J.O., and Hendry B.M. Alkalinization and hemodialysis in severe salicylate poisoning: comparison of elimination techniques in the same patient. Clin Nephrol 50 3 (1998) 178-183
82. Shalkham A.S., Kirrane B.M., Hoffman R.S., et al. The availability and use of charcoal hemoperfusion in the treatment of poisoned patients. Am J Kidney Dis 48 2 (2006) 239-241